Patent · US Expired

Pyrazole derivatives

US7109228B2 · kind B2 · utility

4Cited by
4References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 5, 2002
Grant dateSep 19, 2006
Priority date
Expiry dateApr 20, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to pyrazole derivatives of formula (I)or pharmaceutically acceptable salts, solvates or derivatives thereof, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such, the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.